Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed Streptococcal preparation

Cancer Immunology Immunotherapy

Volumn 22, Issue 3, 1986, Pages 161-168

  Saito, Motoo ^a   Ichimura, Osamu ^a   Kataoka, Motoyuki ^a   Moriya, Yoichiro ^a   Ueno, Kouko ^a   Sugawara, Yutaka ^a   Nanjo, Masaki ^b   Ishida, Nakao ^b  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PICIBANIL; THYMOCYTE ANTIBODY;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; BLOOD AND HEMOPOIETIC SYSTEM; CELLULAR IMMUNITY; DRUG EFFICACY; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOKINE ACTIVATED KILLER CELL; MOUSE; NONHUMAN; PERITONEAL EXUDATE CELL; PERITONEUM; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM;

ANIMALS; ANTILYMPHOCYTE SERUM; BIOLOGICAL PRODUCTS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; INJECTIONS, INTRAPERITONEAL; INTERFERONS; KILLER CELLS; LYMPHOKINES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PICIBANIL;

EID: 0022570343     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/BF00200027     Document Type: Article

References (32)

1. In vitro generation of human activated lymphocyte killer cells: Separate precursors, and mode of generation of NK-like cells and “anomalous” killer cells
2. Adoptive chemoimmunotherapy of a syngeneic murine lymphoma with long-term lymphoid cell lines expanded in T cell growth factor
3. Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2
4. The biochemistry, biology and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell response
5. Evidence for in vivo protection against murine sarcoma virus-induced tumors by T lymphocytes from immune animals
6. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors II. Characterization of effector cells
7. Cytotoxic cells induced in tumor-bearing rats by a streptococcus preparation (OK-432)
8. Augmentation of interleukin 1 and interleukin 2 production by OK-432
9. Inhibition of tumor growth in vivo by macrophages from rat treated with a Streptococcal preparation, OK-432
10. Factors responsible for immune resistance to L1210 murine leukemia in hyperimmune mice
11. Natural cell-mediated cytotoxicity in vivo and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF)
12. Phenotypic heterogeneity of antisyngeneic tumor killer cells (ASTK) generated in allogeneic mixed lymphocyte reactions
13. Induction of nonspecific killer T cells from non-immune mouse spleen cells by culture with interleukin 2
14. Inhibitory effect of a streptococcal preparation (OK-432) on the nucleic acid synthesis in tumor cells in vitro
15. Augmentation of mouse natural killer cell activity by a Streptococcal preparation, OK-432
16. Adoptive immunotherapy of cancer
17. Lymphokine-activated killer cells: Lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2
18. Induction of interferon in mice spleen cells by OK-432, a preparation of Streptococcus pyogenes
19. In vitro production of immune interferon (IFNγ) by murine spleen cells when different sensitizing antigens are used in vitro
20. Activated macrophages are responsible for the tumor inhibitory effect in mice receiving intravenous injection of OK-432
21. Tumor-inhibitory effect of a Streptococcal preparation (NSC-B116209)
22. Functional and morphologic characteristics of interferon treated macrophages
23. Studies on cytotoxicity generated in human mixed lymphocyte cultures. II. Anti-K562 effectors are distinct from allo-specific CTL and can be generated from NK-depleted T cells
24. Alloantigen-induced cytotoxicity against syngeneic tumor cells: Analysis at the clonal level
25. Role of different T cell sets in the rejection of syngeneic chemically induced tumors
26. New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival
27. Clinical studies on cell-mediated immunity in patients with malignant disease
28. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and plural effusion lymphocytes activated by OK-432
29. Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions
30. Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432
31. Clinical value of immunotherapy for lung cancer by the streptococcal preparation, OK-432
32. Streptococcal immunotherapy of a chemical induced murine fibrosarcoma: Effect of dose, route, sham surgery and splenectomy on adjuvant action